lamp
TherApp
 Posted on 31/05/2014 - 10:28
Idea Outline
The problem of non-compliance in the EU generates enormous expenses for PAs, as well as an increasing number of health issues. Here a smart solution is proposed to overcome these problems by means of innovative ICT tools and social medias.

The Challenge
The aim of TherApp is to combat lack of compliance with medical treatment. When we talk about non-compliance we refer to failure to follow a course of prescribed medication. According to WHO non compliance costs around 125,000 million euros every year in the EU. Futhermore the results of a study of the IMS center are really interesting. The study involved 186 countries and analyzed 6 different chronic illnesses: the results of the study highlighted that the cost of non-compliance is about 300,000 million dollars every year. Two thirds of this amount was attributed to the cost of hospitalisation, due to lack of compliance with a course of medication. It’s evident that this is not only a matter of economics or health but, above all, a social issue.

The Solution

TherApp is a technological solution aimed at supporting patients, both dismissed and hospitalized.
Through integration with the EHR, TherApp tracks the patient's drug therapy, warning him/her when it's time to take a prescribed medicine. An interactive response can be provided to confirm the drug assumption.
Biometric monitoring will be possible by means of wearable devices that will update patient’s EHR.
The idea includes e-learning mechanisms for both self-regarding and medications.
Instead, the integration with social media leads to the creation of a health community that will provide users with increased support and awareness. Users will be able to interact with each other on common themes, sharing opinions on drugs or similar issues.


Target group and social impact
The risk of non-compliance involves all the patients following a medical therapy. In particular, the target are those over 65, patients with physical and psychological problems and patients following polytherapy treatments (who can take even more than 10 drugs a day). In addition to patients, national health systems, social welfare systems, doctors and chemists can be interested in this solution. Pilot actions can improve the quality of the prescribed treatment, the quality of life of the patients and can also promote new policies of healthcare spending, leading to huge benefits. A IMS study affirms that interventions to decrease non-compliance would prevent, on average, about 10 million hospitalizations a year in every country and savings of about 140 billion dollars.




Competences of the applicant
The applicants are experts in ICT, medical and legislative fields, have a strong multidisciplinary culture and possess excellent degrees. They have the competences required to complete the project. They have already had the opportunity to interact collaboratively with other professionals in the medical and legal sectors. These competencies will be extremely useful to complete the project.


Video Link
None posted
Social Category
  • Civic Empowerment and Community Engagement
  • Health and Demographic Change
  • Knowledge Society and Education
  • Other

  • Tecnology Category
  • Data
  • Mobile
  • Social Software
  • Web/Internet
  • Other

  • Please log in to Rate this Idea

    As a potential patient, I m a bit troubled by the statement "Sale of aggregate data" under "Revenue Structure" (see figure). For me, selling health related data that - e.g. in the case of rare diseases - may potentially be traced back to individual patients is a no-go!

    that's why they are called aggregate :) not single individuals, but significant samples of populations, so no privacy issues at all :)

    Forza ragazzi!